Impaired atrial electromechanical function and atrial fibrillation promotion in alloxan-induced diabetic rabbits

Cardiology Journal

Volumn 20, Issue 1, 2013, Pages 59-67

  Fu, Huaying ^a   Liu, Changle ^a   Li, Jian ^a   Zhou, Changyu ^a   Cheng, Lijun ^a   Liu, Tong ^a   Li, Guangping ^a  

^a SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Atrial electromechanical function; Atrial fibrillation; Diabetes mellitus

Indexed keywords

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATRIAL ELECTROMECHANICAL FUNCTION; ATRIAL INTERSTITIAL FIBROSIS; ATRIAL REFRACTORY EFFECTIVE PERIOD; ATRIAL REFRACTORY EFFECTIVE PERIOD DISPERSION; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FUNCTION; HEART ELECTROPHYSIOLOGY; HEART HEMODYNAMICS; HEART MUSCLE FIBROSIS; INTERATRIAL CONDUCTION TIME; ISOLATED HEART; MALE; NONHUMAN; RABBIT; TISSUE DOPPLER IMAGING;

ANIMALS; ATRIAL FIBRILLATION; ATRIAL FUNCTION; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FIBROSIS; HEART ATRIA; HEART CONDUCTION SYSTEM; HEMODYNAMICS; MALE; MYOCARDIUM; PERFUSION; RABBITS;

EID: 84873621054     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: 10.5603/CJ.2013.0010     Document Type: Article

References (25)

1. Kannel WB, Benjamin EJ. Current perceptions of the epidemiology of atrial fibrillation. Cardiol Clin, 2009; 27: 13-24.
2. Huxley RR, Filion KB, Konety S, Alonso A. Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation. Am J Cardiol, 2011; 108: 56-62.
3. Movahed MR, Hashemzadeh M, Jamal MM. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol, 2005; 105: 315-321.
4. Lip GYH, Varughese GI. Diabetes mellitus and atrial fibrillation: Perspectives on epidemiological and pathophysiological links. Int J Cardiol, 2005; 105: 319-321.
5. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med, 1995; 98: 476-484.
6. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care, 1998; 21: 1414-1431.
7. Dilaveris PE, Gialafos EJ, Sideris SK et al. Simple electrocardio graphic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J, 1998; 135: 733-738.
8. Cui QQ, Zhang W, Wang H et al. Assessment of atrial electro mechanical coupling and influential factors in nonrheumatic paroxysmal atrial fibrillation. Clin Cardiol, 2008; 31: 74-78.
9. Nagueh SF, Kopelen HA, Lim DS et al. Tissue Doppler imaging consistently detects myocardial contraction and relaxation abnormalities, irrespective of cardiac hypertrophy, in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation, 2000; 102: 1346-1350.
10. Fontes-Sousa APN, Bras-Silva C, Moura C, Areias JC, Leite-Moreira AF. M-mode and Doppler echocardiographic reference values for male New Zealand white rabbits. Am J Vet Res, 2006; 67: 1725-1729.
11. Schiller NB, Shah PM, Crawford M et al. Recommendations for quantitation of the left ventricle by two dimensional echocardiography. American Society of Echocardiography Committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr, 1989; 2: 358-367.
12. Paraskevaidis IA, Dodouras T, Adamopoulos S, Kremastinos DT. Left atrial functional reserve in patients with nonischemic dilated cardiomyopathy: An echocardiographic dobutamine study. Chest, 2002; 122: 1340-1347.
13. Triposkiadis F, Moyssakis I, Hadjinikolaou L et al. Left atrial systolic function is depressed in idiopathic and preserved in ischemic dilated cardiomyopathy. Eur J Clin Invest, 1999; 29: 905-912.
14. Kircher B, Abbott JA, Pau S et al. Left atrial volume determination by biplane two-dimensional echocardiography: Validation by cine computed tomography. Am Heart J, 1991; 121: 864-871.
15. Acar G, Akcay A, Sokmen A et al. Assessment of atrial electro mechanical delay, diastolic functions, and left atrial mechanical functions in patients with type 1 diabetes mellitus. J Am Soc Echocardiogr, 2009; 22: 732-738.
16. Haffajee JA, Lee Y, Alsheikh-Ali AA, Kuvin JT, Pandian NG, Patel AR. Pre-operative left atrial mechanical function predicts risk of atrial fibrillation following cardiac surgery. J Am Coll Cardiol Imaging, 2011; 4: 833-840.
17. Aktoz M, Yilmaztepe M, Tatli E, Turan FN, Umit EG, Altun A. Assessment of ventricular and left atrial mechanical functions, atrial electromechanical delay and P wave dispersion in patients with scleroderma. Cardiol J, 2011; 18: 261-269.
18. Henein M, Zhao Y, Henein MY, Lindqvist P. Disturbed left atrial mechanical function in paroxysmal atrial fibrillation: A speckle tracking study. Int J Cardiol, 2012; 155: 437-441.
19. Aldhoon B, Melenovsky V, Peichl P, Kautzner J. New insights into mechanisms of atrial fibrillation. Physiol Res, 2010; 59: 1-12.
20. Burstein B, Nattel S. Atrial fibrosis: Mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol, 2008; 51: 802-809.
21. Hotta H, Miura T, Miki T et al. Angiotensin II type 1 receptor mediated upregulation of calcineurin activity underlies impairment of cardioprotective signaling in diabetic hearts. Circ Res, 2010; 106: 129-132
22. Rosenkranz S. TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc Res, 2004; 63: 423-432.
23. Kato T, Yamashita T, Sekiguchi A et al. What are arrhythmogenic substrates in diabetic rat atria? J Cardiovasc Electrophysiol, 2006; 17: 890-894.
24. Kato T, Yamashita T, Sekiguchi A et al. AGEs-RAGE system mediates atrial structural remodeling in the diabetic rat. J Cardiovasc Electrophysiol, 2008; 19: 415-420.
25. Liu T, Korantzopoulos P, Li G, Li J. The potential role of thiazolidinediones in atrial fibrillation. Int J Cardiol, 2008; 128: 129-130.